Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 27Other hematologic neoplasm 8Plasma cell 7Lymphoid 7Breast 6Thoracic 4Other neoplasm 3Myeloid 3Gastrointestinal 3Head & Neck 2Gynecologic 2Genitourinary 2Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Head and Neck Neoplasms 2Anemia 1

Interventions

Cisplatin 144Radiotherapy 71Fluorouracil 50Radiotherapy, Intensity-Modulated 45Docetaxel 39Gemcitabine 38Cetuximab 38Carboplatin 31pembrolizumab 25Capecitabine 22Drug Therapy 17toripalimab 14Paclitaxel 14camrelizumab 10Surgical Procedures, Operative 10Nivolumab 10Chemoradiotherapy 10nimotuzumab 9Radiation 9Neoadjuvant Therapy 8Methotrexate 8Magnetic Resonance Spectroscopy 8Chemotherapy, Adjuvant 8nedaplatin 7Thyrotropin Alfa 7Platinum 7tislelizumab 6spartalizumab 6Standard of Care 6Specimen Handling 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Epoetin Alfa × Head & Neck × Clear all
NCT00004917 2020-10-22

Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer

Radiation Therapy Oncology Group

Phase 3 Completed
Classical hematologyHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anemia, Head and Neck Neoplasms

NCT00017277 2012-09-24

Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Terminated
47 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡